Skip to main content
. 2020 May 18;13:1756284820922003. doi: 10.1177/1756284820922003

Figure 1.

Figure 1.

The 484 patients and their outcomes.

CD, Crohn’s disease; IGRA, interferon gamma release assay; ITB, intestinal tuberculosis; UC, ulcerative colitis.